MedTrace Logo

Healing Touch During Chemotherapy Infusions for Women With Breast Cancer

NCT00533663 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2022-06-23

No results posted yet for this study

Summary

To study if Healing Touch is effective during chemotherapy treatment for breast cancer

Conditions

Interventions

PROCEDURE

Healing Touch

every other week (during their infusion)

OTHER

Standard care

Adriamycin, cyclophosphamide, and paclitaxel administered as standard of care

PROCEDURE

guided relaxation

Sponsors & Collaborators

Principal Investigators

  • Kathy Turner, RN, NP · Stanford University

  • Alice "Ellie" Guardino, RN, NP · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00533663 on ClinicalTrials.gov